Market revenue in 2021 | USD 1,466.7 million |
Market revenue in 2028 | USD 1,639.7 million |
Growth rate | 1.6% (CAGR from 2021 to 2028) |
Largest segment | Reagents & kits |
Fastest growing segment | Reagents & Kits |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Reagents & Kits, Analyzers/Instruments, Software & Services |
Key market players worldwide | BioMerieux SA, Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Becton Dickinson & Co, Bio-Rad Laboratories Inc Class A, Beckman Coulter |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to immunoassay analyzers market will help companies and investors design strategic landscapes.
Reagents & kits was the largest segment with a revenue share of 65.92% in 2021. Horizon Databook has segmented the Germany immunoassay analyzers market based on reagents & kits, analyzers/instruments, software & services covering the revenue growth of each sub-segment from 2016 to 2028.
Germany immunoassay analyzers market is expected to witness substantial growth owing to its supportive healthcare policies. Moreover, presence of a large geriatric population in this region is a major driver for the market.
According to UN population data, one in every 20 people in Germany is above 80 years, and the number is expected to increase to six by 2050. With age, the risk of developing chronic diseases, such as cardiovascular diseases, diabetes, & neurovascular disorders, increases due to the onset of senescence and decreased immunity levels.
Furthermore, increasing number of product approvals and launch of novel immunoassay analyzers by leading manufacturers are anticipated to support the market growth in Germany. For instance, in April 2021, Siemens Healthineers received the CE Mark for its Atellica VTLi Patient-Side Immunoassay Analyzer.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany immunoassay analyzers market , including forecasts for subscribers. This country databook contains high-level insights into Germany immunoassay analyzers market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account